FinTechFunding

New Equilibrium Biosciences: Raises $10M in Seed Funding

  • New Equilibrium Biosciences, Mass.-based company that advances a rational drug design against intrinsically disordered proteins (IDPs), closed a $10m in seed funding
  • RA Capital Management made the investment
  • The company intends to use the funds to scale up R&D facility, expand the team, and accelerate programs targeting IDPs while exploring strategic partnerships
  • New Equilibrium also provides a platform that reveals opportunities for structure-based design by learning biophysics with AI
  • NEQ’s platform combines AI and biophysics to reveal experimentally-invisible conformations of shapeshifting proteins
  • This technology enables the rational design of drugs targeting the elusive class of intrinsically disordered proteins
Previous article
BrightPlan: Raises $9.5M in Series A Funding
Next article
infiniDome: Raises $2.4M Pre-Series A Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...
FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...